Implementation of the Golden Hour for Preterm Infants : a Quality Improvement Study

March 7, 2022 updated by: Tribolet Sophie, Centre Hospitalier Universitaire de Liege

Implementation of the "Golden Hour", an Initial Standardized Stabilization of Preterm Less Than 31 Weeks and/or 1300 g : a Quality Improvement Study

Effective initial stabilization of preterm neonates in the initial 60 minutes of life ("golden hour") was shown to improve outcomes. Keys components include anticipative and collaborative approach, respiratory support, thermal regulation and early initiation of parenteral nutrition. The objective is to complete the admission within 60 minutes of delivery.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 1 hour (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Premature younger than 31 weeks of gestational age or less than 1300 g expected

Description

Inclusion Criteria:

  • Premature infants (< 31 weeks' gestation)
  • Infants with expected weight less than 1300 g
  • Inborn babies

Exclusion Criteria:

  • Infants outborn
  • Infants with major congenital anomalies (laparoschisis, omphalocèle, diaphragmatic hernia, …)
  • Parental refusal

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
premature infants
premature infants less than 31 weeks of gestation or weighting less than 1300 g

This is a quality improvement project to evaluate the implementation of "Golden hour", a standardized stabilization during the first hour of life in inborn preterm infants younger than 31 weeks of gestational age or weighting less than 1300 g in the NICU of the University of Liege.

There is no comparative arm.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Completion of the procedure : closing time of the incubator
Time Frame: 1 hour
Number of minutes of life at incubator closure
1 hour
Glycemia at admission and within 24 hours
Time Frame: 24 hours
blood glucose measurement on admission and then every 3 hours for the first 24 hours of life
24 hours
Thermal stability : temperature at admission and at the end of the procedure
Time Frame: 1 hour
1 hour
Mortality rate
Time Frame: 3 months
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Process of the procedure:
Time Frame: 1 hour
Number of minutes of life at initiation of parenteral nutrition, caffeine and antibiotics administration.
1 hour
Incidence of hypotension and bradycardia
Time Frame: 1 hour
1 hour
Intubation rate and duration of mechanical ventilation
Time Frame: 3 months
Number of hours of mechanical ventilation
3 months
Need for surfactant administration and time of administration
Time Frame: 3 days
Number of hours of life at surfactant administration
3 days
Comorbidities of prematurity: NEC, BPD, ROP, sepsis, PDA, cPVL, IVH
Time Frame: 3 months
3 months
Duration of hospital stay (only if no transfer)
Time Frame: 3 months
3 months
Caregiver's perception of the procedure: stress…
Time Frame: 24 hours
use of a questionnaire adapted from the "Teamwork Perceptions Questionnaire (T-TPQ)"
24 hours
Parental experience of the procedure
Time Frame: 24 hours
24 hours
Conditions of the procedure : realization during the night shift and team composition
Time Frame: 24 hours
collection of the time and date of performance and the number of nurses, doctors, fellows,...
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 10, 2022

Primary Completion (Anticipated)

March 1, 2023

Study Completion (Anticipated)

June 1, 2023

Study Registration Dates

First Submitted

December 1, 2021

First Submitted That Met QC Criteria

December 14, 2021

First Posted (Actual)

January 4, 2022

Study Record Updates

Last Update Posted (Actual)

March 9, 2022

Last Update Submitted That Met QC Criteria

March 7, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Premature Birth

Subscribe